Section Arrow
Quote
PVLA.NASDAQ
- Palvella Therapeutics Inc
Quotes are at least 15-min delayed:2025/07/23 05:05 EDT
Pre Market
Last
 --
-- (--)
Bid
30.92
Ask
47
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 36
+5 (+16.13%)
Day High 
36.205 
Prev. Close
31 
1-M High
31.5 
Volume 
645.01K 
Bid
30.92
Ask
47
Day Low
31.01 
Open
31.01 
1-M Low
20.35 
Market Cap 
342.73M 
Currency USD 
P/E 13.7 
%Yield -- 
10-SMA 27.95 
20-SMA 25.31 
50-SMA 24.21 
52-W High 36.205 
52-W Low 7.34 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.08/-3.90
Enterprise Value
342.73M
Balance Sheet
Book Value Per Share
5.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
24.01
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.053+0.002+3.92%-- 
Pre Market 0.0549 +0.0019 +3.58%
PLRZPolyrizon Ltd1.45+0.5422+59.73%-- 
Pre Market 1.92 +0.47 +32.41%
REPLReplimune Group2.805-9.52-77.24%-- 
Pre Market 2.78 -0.025 -0.89%
IOVAIovance Biotherapeutics3.13+0.64+25.70%-- 
Pre Market 3.16 +0.03 +0.96%
TNFATNF Pharmaceuticals Inc.0.107-0.0224-17.31%-- 
Pre Market 0.1075 +0.0005 +0.47%
Quotes are at least 15-min delayed：2025/07/23 05:05 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.